Cytokine-mediated peripheral albumin degradation and decreased oral intake leading to relative protein deficiency have both been specifically attributed to patients with advanced cancer, in which hypoalbuminemia has been explored as a clinical biomarker for many years (Gatta et al., 2012; Kim et al., 2017; Suzuki et al., 2013). The gene discussed is ALB; the disease is cancer.